⚗️ NEOGEN CHEMICALS — THE BATTERY CHEMISTRY OPPORTUNITY! 🔋

The EV revolution needs more than batteries. It needs the chemistry that makes those batteries work. Neogen Chemicals operates in specialised chemical manufacturing, with exposure to organolithium compounds, inorganic chemicals and battery materials. Its long-term story lies in moving beyond its established specialty-chemicals business and scaling its battery-chemistry ambitions. 📊 Q1 FY27: GROWTH IS ACCELERATING 💰 Revenue: ₹250.3 crore, up 34% YoY. 🚀 EBITDA: ₹48.2 crore, up 53%. 📈 Net profit: ₹17.1 crore, up around 67%. 🔥 Consolidated EBITDA margin improved to 19.3%, versus 16.9% a year earlier. Neogen Ionics, its battery-chemicals subsidiary, generated ₹19 crore in revenue compared with ₹5 crore in the year-ago quarter. 🚀 WHAT COULD DRIVE THE NEXT LEG? ✅ Battery materials: Growing battery manufacturing capacity could create demand for electrolyte chemicals and related materials. ✅ Specialty chemicals: Organolithium and inorganic chemicals provide an established business alongside the newer battery opportunity. ✅ Capacity expansion: The Dahej plant reconstruction and battery-chemicals investments could support future growth as projects ramp up. ✅ Operating leverage: If volumes rise and new facilities utilise capacity efficiently, profitability could improve further. ⚠️ THE RISKS YOU CANNOT IGNORE Finance costs rose approximately 64% YoY to ₹20.8 crore in Q1 FY27, reflecting higher debt and working-capital requirements. The Dahej reconstruction, capital expenditure, commissioning timelines and slower-than-expected battery-cell expansion could all affect returns. 🎯 THE BOTTOM LINE Neogen combines a growing specialty-chemicals business with a potentially significant battery-materials opportunity. But the real test is whether expansion translates into sustainable cash flow, manageable debt and consistent earnings. The battery opportunity is exciting. Execution will decide the chemistry of returns.